Ryan Baker | Head-IR |
Michel Detheux | President and CEO |
Matthew Gall | CFO |
Joe Lager | CMO |
Daina Graybosch | SVB Leerink |
Anupam Rama | JP Morgan |
David Nierengarten | Wedbush Securities |
Swayampakula Ramakanth | H.C. Wainwright |
Good afternoon and welcome to the iTeos Therapeutics’ Third Quarter 2021 Financial Results Conference Call. This time, all participants are in a listen-only mode.
Following the formal remarks, we will open the call up for your questions. Please be advised that this call is being recorded at the company’s request. At this time I would like to turn it over to Ryan Baker, Head of Investor Relations at iTeos.